Here’s a standalone **“Future Vision + Trust & Reproducibility”** doc you can tack onto your repo / writeup as a forward-looking appendix. It assumes the hackathon demo is v0 and this is “where we’re going.”

---

# MorphoLens – Future Vision, Trust, and Reproducibility

## 1. Purpose & Scope

This document describes the **future direction** of MorphoLens beyond the hackathon MVP, with a focus on:

* The **long-term product vision** (what MorphoLens could become in 1–3 years).
* A concrete **trust, safety, and reproducibility** strategy grounded in emerging standards for medical imaging AI and bio-image analysis.

This is *not* a commitment for the weekend; it’s a roadmap and philosophy for how MorphoLens grows into something real labs can rely on.

---

## 2. Future Vision: MorphoLens as an “Agentic Morphometry OS”

### 2.1 From Tang OA demo → general agentic morphometry

The Tang OA μCT workflow is our first “hero story,” but the long-term vision is:

> MorphoLens becomes an **agentic operating system for morphometry** – a place where researchers converse with their data, and agents orchestrate segmentation, measurement, and interpretation across many imaging modalities and disease models.

Over time, MorphoLens should:

1. **Support multiple modalities**

   * μCT, histology slides, brightfield/fluorescence microscopy, potentially MRI/CT subregions in the future.
   * Each with domain-specific measurement “recipes” (e.g., OA geometry, neurite morphology, tumor–stroma ratios).

2. **Host a library of reusable “measurement recipes”**

   * Tang OA indices (distal femur W/L, tibial IIOC H/W).
   * Cell/nucleus morphology metrics.
   * Vessel density, bone microarchitecture indices, etc.
   * Recipes are small, versioned bundles: what to segment, what landmarks to place, and what formulas to compute.

3. **Provide a unified agent layer on top**

   * A **chat agent** that:

     * Reads PDFs and protocols,
     * Chooses measurement recipes,
     * Coordinates segmentation and measurement agents,
     * Synthesizes results into scientific narratives.
   * **Canvas agents** that:

     * Interact with images (SAM prompts, layer editing),
     * Place and adjust landmarks,
     * Ask for human confirmation when uncertain.
   * **Analysis agents** that:

     * Compare cohorts,
     * Propose simple statistical tests,
     * Generate figures, captions, and result summaries.

4. **Integrate into real research pipelines**

   * Connect to lab data stores (e.g., shared μCT volumes, LIMS exports).
   * Export clean artifacts: CSVs, figure panels, and “analysis manifests” that fully describe what was done.

---

## 3. Trust & Safety Framework (Future State)

We intend to align MorphoLens with emerging frameworks for trustworthy AI in medical imaging, especially **FUTURE-AI** (Fairness, Universality, Traceability, Usability, Robustness, Explainability) and the **CLAIM** reporting checklist for imaging AI.

The long-term principles:

1. **Traceable:** Every output (mask, distance, index, interpretation) is linked to its inputs and code.
2. **Usable & Explainable:** Scientists can understand and inspect what the system did, not just see a final number.
3. **Robust (within scope):** For supported tasks, performance is consistent across users, sites, and reasonable data variation.
4. **Human-centered:** The system **augments** scientists, never replaces them as the final decision-makers.
5. **Governed:** There are clear boundaries on intended use, failure modes, and monitoring.

These mirror both FUTURE-AI and broader calls for standardized, documented workflows in bio-image analysis and digital pathology.

---

## 4. Reproducibility & Workflow Governance

### 4.1 Versioned measurement recipes

Future MorphoLens will treat each analysis flow as a **versioned recipe**, e.g.:

* `tang_oa_v1.0`

  * Inputs: μCT knee slice(s), voxel size.
  * Segmentation: SAM3 prompt template for femur/tibia.
  * Landmark rules: how to derive condylar edges, groove midpoint, IIOC height.
  * Indices: femur W/L, tibial IIOC H/W, group thresholds.
  * Output schema: metrics JSON + overlays.

Key properties:

* **Immutable versions:** Once released, a recipe version never changes; updates create `v1.1`, `v2.0`, etc.
* **Shareable configs:** Labs can export/import recipes, letting them standardize analysis across groups and time.
* **Discoverability:** Recipes can be browsed and searched (similar to BIAFLOWS / NEUBIAS concepts for bioimage workflows).

This addresses a major pain point highlighted in bioimage-analysis literature: workflows are often under-documented and hard to reproduce across labs.

### 4.2 Provenance graph for every result

Long-term, MorphoLens will maintain a **provenance graph** per analysis:

* Nodes:

  * Raw inputs (images, PDFs, CSVs).
  * Intermediate artifacts (segmentations, masks, landmarks, cropped views).
  * Measurements (distances, areas, indices).
  * Narrative summaries (LLM outputs).
* Edges:

  * Processing steps (e.g., “applied SAM3 with prompt X,” “computed femur width from landmarks A/B”).
  * Agent calls (which agent, which tool, which parameters).

Researchers should be able to:

* Click any metric (e.g., “Femur W/L = 1.33”) and see:

  * The image with the lines,
  * The landmarks,
  * The formula and recipe version.
* Export a “manifest” (JSON or similar) that fully describes an analysis for publication or peer labs.

This follows suggestions from reproducible image-analysis guides that emphasize logging not only code, but parameters, ROIs, and end-to-end steps.

---

## 5. Data Privacy & Safety

For a future production system (not just the hackathon demo):

1. **Local-first computation**

   * Whenever possible:

     * Segmentation, measurement, and geometric calculations run **in the browser** or on a lab-controlled server.
   * Only minimal, **de-identified** representations (e.g., downsampled crops or derived features) are sent to external LLMs when necessary.

2. **Configurable PHI boundaries**

   * Labs can configure:

     * Which fields are allowed in prompts (e.g., no patient IDs, dates of birth).
     * Whether image sending to cloud models is allowed at all.

3. **Model choice and deployment flexibility**

   * Support:

     * Hosted Gemini for early research.
     * Later: on-premise or VPC-hosted models for sensitive environments.
   * Align this with health-AI guidance that stresses privacy and ethical deployment for imaging AI tools.

4. **Clear intended-use labeling**

   * MorphoLens will explicitly state:

     * It is a **research tool**, not a clinical diagnostic device.
     * It should not be used to make direct patient care decisions.
   * This is consistent with CLAIM-style expectations to clearly define intended clinical role.

---

## 6. Validation, Benchmarking & Monitoring

### 6.1 Benchmarks against expert measurements

Following the pattern in digital pathology and imaging AI, where automated systems are validated against expert scores and shown to improve reproducibility,  MorphoLens will:

* Build **reference datasets**:

  * Curated μCT and slide images with:

    * Expert manual measurements (Amira/ImageJ),
    * Established labels (e.g., MMS vs control, aged vs adult, GM-/- vs WT).
* Evaluate:

  * Agreement between:

    * Human manual measurements,
    * MorphoLens’ automated proposals,
    * Human-corrected measurements in MorphoLens.
  * Inter-observer variability with and without MorphoLens.

Goals:

* Show that for supported workflows:

  * MorphoLens **reduces inter-observer variability** and improves consistency—similar to how QuPath and modern DIA have improved reproducibility for Ki-67, CD3, PD-L1, and other markers.

### 6.2 Continuous monitoring

As recommended by FUTURE-AI, trustworthy medical imaging AI should be monitored across its lifecycle.

Future MorphoLens will include:

* **Drift monitoring**

  * Track performance metrics (error vs ground truth) as site protocols, scanners, or stain protocols change.
* **Agent behavior logging**

  * Maintain logs of:

    * Which tools agents call,
    * How often humans override or correct results,
    * Where errors cluster (by modality, protocol, or cohort).
* **Feedback loops**

  * Allow labs to flag:

    * Bad segmentations,
    * Wrong measurements,
    * Misleading interpretations.
  * Use these flags to improve recipes and prompts over time.

---

## 7. Risk Analysis & Mitigations

Key risks and planned mitigations in the “real” product:

1. **Hallucinated or over-confident interpretations**

   * Mitigation:

     * Constrain Gemini to **summarize provided numbers and docs**, not invent new thresholds or findings.
     * Use structured prompts that always pass explicit metrics and references.
     * Ask it to state uncertainty and suggest validation where appropriate.

2. **Out-of-distribution data**

   * Mitigation:

     * Detection heuristics and/or secondary models to flag when:

       * Imaging parameters differ from training/validation sets,
       * Anatomy / modality doesn’t match recipe assumptions.
     * In such cases, MorphoLens can:

       * Fall back to a conservative baseline (or no automated result),
       * Ask the user to confirm or manually operate.

3. **Over-reliance on AI outputs**

   * Mitigation:

     * UX that:

       * Always shows overlays and raw metrics,
       * Encourages manual inspection (“Review landmarks before accepting.”),
       * Makes it easy to override and re-run.
     * Clear disclaimers on the research-only nature of outputs.

4. **Unclear responsibility boundaries**

   * Mitigation:

     * Documented roles:

       * MorphoLens as analysis assistant,
       * Scientist as final arbiter.
     * Alignment with frameworks that stress human accountability in medical AI decisions.

---

## 8. Roadmap: From Hackathon Demo to Future System

### Near term (hackathon / v0.x)

* Tang OA “hero demo”:

  * Single-image analysis,
  * Simple recipes embedded in code,
  * Chat → segmentation → measurements → explanation loop.
* Light visibility:

  * Show overlays and numbers,
  * Basic correction (drag line, recompute).

### Medium term (v1.x)

* Introduce **explicit recipes** (Tang OA, a couple of others).
* Basic provenance:

  * Per-analysis manifest (image id, recipe version, metrics).
* Small internal benchmark:

  * Compare MorphoLens vs manual for a limited dataset.

### Longer term (v2.x+)

* Full recipe registry & sharing between labs.
* Rich provenance graph + in-app inspection tooling.
* Validation and monitoring aligned with FUTURE-AI and CLAIM-style reporting for key workflows.
* Expanded agent ecosystem:

  * Dedicated canvas agents,
  * More complex multi-image cohort analysis,
  * Deeper integration with lab infrastructure.

---

## 9. Summary

Short version of this doc:

* **Future vision:**
  MorphoLens evolves from a Tang OA demo into a general **agentic OS for morphometry**, where chat-controlled agents perform segmentation and measurements across many imaging workflows.

* **Trust & safety:**
  It will be built in line with **FUTURE-AI** and **CLAIM** principles: traceable, explainable, robust within scope, with humans firmly in the loop.

* **Reproducibility:**
  The long-term design centers on **versioned measurement recipes**, **provenance graphs**, and **benchmarking** against expert measurements—following the trajectory of modern bioimage analysis and digital pathology, where standardized workflows and DIA have already improved consistency and reduced inter-observer variability.

For the hackathon, you’ll **demo the agentic magic**. This document tells judges (and future collaborators) how that magic can grow into something serious enough to trust with real research over the coming years.
